— Know what they know.
Not Investment Advice

ACTU NASDAQ

Actuate Therapeutics Inc
1W: -16.6% 1M: -12.9% 3M: -41.4% YTD: -59.9% 1Y: -77.2%
$2.38
-0.04 (-1.65%)
 
Weekly Expected Move ±20.7%
$2 $2 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $56.9M mcap · 9M float · 1.62% daily turnover · Short 55% of daily vol

Balance Sheet Trends

Total Assets
$14M +50.6% ▲
3Y CAGR: -11.8%
Total Liabilities
$6M -33.7% ▼
3Y CAGR: +2.6%
Shareholders Equity
$8M +7505.6% ▲
3Y CAGR: -18.9%
Cash & Investments
$13M +52.3% ▲
3Y CAGR: -13.7%
Total Debt
$405K +0.0% ▲
3Y CAGR: +0.0%
Net Debt
-$13M -47.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$20M$3M$9M$13M
Short-Term Investments$0$0$0$0
Cash & ST Investments$20M$3M$9M$13M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$34K$37K$0$484K
Total Current Assets$20M$3M$9M$14M
Property, Plant & Equip.$0$0$0$0
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0$0$111K$392K
Total Non-Current Assets$0$0$111K$392K
Total Assets$20M$3M$9M$14M
— Liabilities —
Accounts Payable$2M$3M$2M$2M
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$0
Other Current Liabilities$2M$278K$0$4M
Total Current Liabilities$4M$7M$9M$6M
Long-Term Debt$405K$0$0$405K
Other Non-Current Liab.$901K$96M$412K$0
Total Non-Current Liabilities$1M$96M$412K$405K
Total Liabilities$6M$103M$9M$6M
— Equity —
Common Stock$3$2$20$23
Retained Earnings-$80M-$105M-$132M-$155M
Accumulated OCI$0-$0$0$0
Total Stockholders Equity$15M-$100M$104K$8M
Total Liabilities & Equity$20M$3M$9M$14M
— Key Metrics —
Total Debt$405K$0$0$405K
Net Debt-$20M-$3M-$9M-$13M
Total Investments$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms